Joint Exhibition at Expo 2025 Osaka, Kansai: “Near-Future Breast Cancer Screening Through Breath Analysis”
— Recreating Next-Generation Medical Experiences in the Metaverse —

MediScan Inc. (Headquarters: Chuo-ku, Tokyo; CEO: Koichiro Yoshino; hereinafter “MediScan”) and PERSOL Marketing Inc. (Headquarters: Shinjuku-ku, Tokyo; CEO: Hiroyuki Suzuki; hereinafter “PERSOL Marketing”) have been selected to exhibit at Expo 2025 Osaka, Kansai as members of the Metaverse Promotion Council (Representative Director: Takeshi Yoro), a partner of the Future Society Showcase project “Future Life Expo / Future Life Experience.” The exhibition will present a video showcasing a future medical experience utilizing the metaverse, highlighting new possibilities born from the fusion of healthcare and technology.
■ Background
MediScan is founded on the mission of “delivering optimal healthcare to as many people as possible,” and is engaged in the research and development of a “breath analysis screening kit” that detects signs of breast cancer simply by breathing into the device, as well as providing online medical consultation services.
PERSOL Marketing is a pioneer in metaverse space operation support, having accumulated extensive expertise in the field. The company defines the metaverse as “a new workspace that expands human behavioral domains and choices,” and aims to create employment opportunities and expand work options within virtual spaces.
With support from the Metaverse Promotion Council, this exhibition was realized through the shared vision of both companies: “to bridge gaps in age, gender, and regional access, and to create a future where everyone can access healthcare.”
■ Exhibition Details
The exhibition features a video depicting a next-generation medical experience in which a patient who has taken a breath analysis test at home visits a metaverse “Clinic of the Future” to receive their results. In this virtual clinic, patients and doctors can communicate through avatars, enabling convenient remote healthcare while maintaining mutual privacy.
If the at-home screening kit currently under development and the metaverse as a new healthcare platform become a reality, they have the potential to help address the shortage of doctors in rural areas caused by an aging population and to reduce regional disparities in healthcare access. At Expo 2025 Osaka, Kansai — themed around “a place where diverse values intersect” — we will share new possibilities for healthcare and insights for solving social challenges with the world.

■ Exhibition Overview
Theme: “Near-Future Breast Cancer Screening Through Breath Analysis”
Dates: August 31 (Sun) – September 27 (Sat), 2025
Venue: Future Life Village (FLV), Expo 2025 Osaka, Kansai
■ Comment from Koichiro Yoshino, CEO of MediScan Inc.

In Japan, more than 90,000 women are diagnosed with breast cancer each year, making early detection increasingly critical. However, screening rates remain low compared to other developed countries, largely due to the psychological barriers associated with mammography, such as pain and anxiety. We are developing a “breath analysis screening kit” that can detect signs of breast cancer simply by breathing into the device, and we believe it holds great potential as a new approach that complements the limitations of conventional screening methods.

Because this screening kit can be handled as a dried specimen, we aim to build a society where it can reach areas with limited access to healthcare, and we envision future applications for a wide range of diseases. In addressing such challenges of “healthcare that is hard to reach,” our collaboration with PERSOL Marketing Inc., which has established platforms for social implementation through the metaverse, is truly meaningful. How can technology connect people with healthcare? We hope that through this exhibition, as many people as possible will catch a glimpse of the possibilities of “next-generation healthcare.”
■ About the Metaverse Promotion Council < https://jmpc.jp/ >
Established: March 2022
Representative Director: Takeshi Yoro
Location: Prince-dori Building 2F, 3-33 Kioicho, Chiyoda-ku, Tokyo
Activities: Founded in March 2022, the Council explores “the way humans are meant to live” through cutting-edge digital technologies, aiming to preserve Japanese living culture and industries while building new cultural and economic spheres. Recognizing that Japan faces complex challenges such as a declining birthrate, aging population, population concentration, and regional decline, the Council emphasizes the importance of supplementing social infrastructure through digital technology and expanding related populations, especially in rural areas. It also facilitates multifaceted discussions on the potential and impact of emerging digital technologies including the metaverse and AI, and believes in the need for opportunities to experience unknown worlds. At Expo 2025 Osaka, Kansai, the Council provides venues for experiencing and exploring future society together with local governments, educational institutions, and regional businesses.
■ About PERSOL Marketing Inc. < https://www.persol-mk.co.jp/sales/service/metasolution/ >
Established: January 1987
Representative: CEO Hiroyuki Suzuki
Headquarters: Shinjuku Miyuki Building, 3-27-4 Shinjuku, Shinjuku-ku, Tokyo
Business Overview: PERSOL Marketing is a specialized sales and marketing company within the PERSOL Group, providing services including staffing and outsourcing. The company combines in-person, remote, and metaverse (virtual space) solutions to deliver optimal sales strategies for every stage of its clients’ sales processes.
The company is also the official authorized distributor in Japan for Virbela, sold domestically by Gaia Link Inc.
■ About MediScan Inc. < https://www.mediscan.co.jp/ >
Established: July 7, 2021
Representative: CEO Koichiro Yoshino
Headquarters: Ginza Astel Building, 7-2-6 Ginza, Chuo-ku, Tokyo
Business Overview: Research, development, manufacturing, and sales of breath analysis screening devices for the early detection of breast cancer
< Inquiries regarding this exhibition from the general public and media >
MediScan Inc.
Phone: 03-6280-6895 | Email: info@mediscan.co.jp